Search results
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Zacks via Yahoo News· 6 hours agoECL’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being...
Marcus Willis, Wimbledon's Everyman of yesteryear who played Roger Federer, returns in doubles
Associated Press via Yahoo News· 7 hours agoWillis had not competed at the grass-court Grand Slam tournament since a run to the third round of...
Vishay (VSH) Expands Portfolio With Sprague TX3 Capacitors
Zacks via Yahoo News· 7 hours agoMoreover, the recent launch will enable Vishay to capitalize on the solid growth opportunity present...
US election 2024: will Joe Biden step aside and who could replace him as Democratic nominee?
Evening Standard via Yahoo News· 7 hours ago“He couldn’t do it,” he said. After his head-to-head with Mr Trump, CNN asked viewers who had won —...
Alphabet (GOOGL) Boosts Android Efforts With App Upgrades
Zacks via Yahoo News· 7 hours agoAlphabet’s GOOGL shares have rallied 33.2% in the year-to-date period, outperforming the Zacks...
Adobe (ADBE) Boosts Generative AI Solutions With Content Hub
Zacks via Yahoo News· 7 hours agoSolid momentum in Google’s Vertex AI, which enables developers to train, tune, augment and deploy...
‘Despicable Me 4’ Lights $27M Wednesday, ‘A’ CinemaScore; $120M 5-Day Opening Still In Reach;...
Deadline via Yahoo News· 8 hours agoJULY 4TH AM UPDATE: Illumination/Universal’s Despicable Me 4 came in a little lighter than spotted...
Verizon (VZ) Looks to Offer Uninterrupted Service Amid Outage
Zacks via Yahoo News· 8 hours agoVerizon (VZ) is set to keep its services uninterrupted in the face of possible power outages, which...
Here's Why You Should Hold Brighthouse Financial (BHF) Now
Zacks via Yahoo News· 9 hours agoBrighthouse Financial (BHF) gains from higher annuity and life insurance sales, conservative...
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo News· 9 hours agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...